Literature DB >> 7741181

Longitudinal survey of Loa loa filariasis in southern Cameroon: long-term stability and factors influencing individual microfilarial status.

A Garcia1, L Abel, M Cot, S Ranque, P Richard, M Boussinesq, J P Chippaux.   

Abstract

A longitudinal, one-year survey of Loa loa infection was carried out in an endemic area of southern Cameroon. Parasitologic samplings (calibrated thick blood smears) were performed every two months to study the evolution of loiasis infection at both the population and the individual level. The mean number of measurements by subject was 3.8 (range 1-6). At the population level, prevalence of infection and microfilarial load were found to be very stable over time. This observation is consistent with the existence of an important reserve of parasitic material available for vectors and the maintenance of high levels of transmission. At the individual level, both the microfilarial status (microfilaremic/nonmicrofilaremic) and the level of parasitemia showed a remarkable stability over time. Age was the relevant factor that influenced the individual microfilarial status in the whole population. When only microfilaremic individuals were taken into account, age did not influence the level of microfilaremia, suggesting that loiasis could be considered as a noncumulative disease. The stability of individual microfilarial status and the pattern of infection variations observed with age support the view that genetic factors might be involved in host defense mechanisms against loiasis infection.

Entities:  

Mesh:

Year:  1995        PMID: 7741181     DOI: 10.4269/ajtmh.1995.52.370

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.

Authors:  Fanny Legrand; Jesica Herrick; Michelle Makiya; Roshan Ramanathan; Reagan Thompson; Shakuntala Rampertaap; Jennifer Stoddard; JeanAnne Ware; Michael P Fay; Nicole Holland-Thomas; Thomas B Nutman; Amy D Klion
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.

Authors:  David J Blok; Joseph Kamgno; Sebastien D Pion; Hugues C Nana-Djeunga; Yannick Niamsi-Emalio; Cedric B Chesnais; Charles D Mackenzie; Amy D Klion; Daniel A Fletcher; Thomas B Nutman; Sake J de Vlas; Michel Boussinesq; Wilma A Stolk
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

3.  Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.

Authors:  A A Hassan; B Akinsanya; N Iyase; F O Owagboriaye
Journal:  Korean J Parasitol       Date:  2011-06-14       Impact factor: 1.341

4.  Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.

Authors:  Sébastien Ds Pion; Hugues Nana-Djeunga; Yannick Niamsi-Emalio; Cédric B Chesnais; Hugo Deléglise; Charles Mackenzie; Wilma Stolk; Daniel A Fletcher; Amy D Klion; Thomas B Nutman; Michel Boussinesq; Joseph Kamgno
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 25.071

5.  Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.

Authors:  Olivier Bouchaud; Sophie Matheron; Anne Loarec; Jean Dupouy Camet; Patrice Bourée; Nadine Godineau; Isabelle Poilane; Johann Cailhol; Eric Caumes
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.